**Question:** Rapid termination of the action of Suxamethonium is due to -

**Core Concept:** Suxamethonium is a short-acting, non-depolarizing neuromuscular blocking agent used during general anesthesia to paralyze skeletal muscles temporarily. Its action is mediated through competitive antagonism of the acetylcholine at the neuromuscular junction.

**Why the Correct Answer is Right:** The correct answer is due to the presence of a structurally related compound called Succinylcholine, which is a derivative of Suxamethonium. Succinylcholine has an additional methylene group (-CH2-) attached to the steroid ring compared to Suxamethonium. This structural modification causes a more potent and faster onset of neuromuscular blockade, as well as a shorter duration of action. The rapid termination of Suxamethonium's action is due to the conversion of the drug to Succinylcholine through hydrolysis by the enzyme acetylcholinesterase. Succinylcholine produces a more potent blockade and has a shorter duration of action, leading to the rapid recovery of spinal reflexes and neuromuscular function.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because Succinylcholine itself is responsible for the faster onset and recovery of neuromuscular blockade, not its hydrolysis by acetylcholinesterase.

B. This option is incorrect as acetylcholinesterase is responsible for the hydrolysis of Succinylcholine, not Suxamethonium.

C. This option is incorrect because the hydrolysis of Suxamethonium by acetylcholinesterase leads to the formation of Succinylcholine, not a less potent compound.

D. This option is incorrect because Succinylcholine has a more potent neuromuscular blocking effect than Suxamethonium and is responsible for the rapid recovery of spinal reflexes and neuromuscular function.

**Clinical Pearl:** Understanding the pharmacology of Suxamethonium and Succinylcholine is crucial for safe and effective management of neuromuscular blockade during anesthesia. This knowledge is essential for selecting the appropriate agent for a given clinical scenario, considering the desired duration of action, onset time, and recovery characteristics. Rapid hydrolysis of Suxamethonium by acetylcholinesterase leads to the formation of Succinylcholine, which has a shorter duration of action and faster recovery, making it advantageous in situations where rapid neuromuscular relaxation and recovery are essential.